Parma, Italy

Roberto Rastelli




Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Roberto Rastelli

Introduction

Roberto Rastelli is a notable inventor based in Parma, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for dry powder inhalers. His work focuses on enhancing the delivery of low-dosage strength active ingredients to patients, which is crucial for effective respiratory treatments.

Latest Patents

Roberto Rastelli holds a patent for "Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient." This invention provides a formulation that can be administered as a dry powder for inhalation, ensuring efficacious delivery of low-dosage strength active ingredients to the low respiratory tract of patients. The formulation consists of microparticles made from a low-dosage strength active ingredient and an excipient. The mean mass diameter (MMD) of these microparticles ranges between 2 and 15 microns, with at least 10% of the microparticles having a mass diameter (MD) greater than 0.5 microns. The patent also details the process of preparation for this innovative formulation.

Career Highlights

Roberto Rastelli is associated with Chiesi Farmaceutici S.p.A., a company renowned for its commitment to research and development in the pharmaceutical sector. His work at Chiesi has allowed him to focus on creating effective inhalation therapies that improve patient outcomes.

Collaborations

Throughout his career, Roberto has collaborated with esteemed colleagues, including Roberto Bilzi and Angela Armanni. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.

Conclusion

Roberto Rastelli's contributions to pharmaceutical formulations demonstrate his commitment to improving respiratory therapies. His innovative patent reflects a significant advancement in the delivery of medications, ultimately benefiting patients in need of effective treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…